These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6434704)

  • 1. Effect of dopamine system activation on substantia nigra pars reticulata output neurons: variable single-unit responses in normal rats and inhibition in 6-hydroxydopamine-lesioned rats.
    Waszczak BL; Lee EK; Tamminga CA; Walters JR
    J Neurosci; 1984 Sep; 4(9):2369-75. PubMed ID: 6434704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single unit responses of substantia nigra pars reticulata neurons to apomorphine: effects of striatal lesions and anesthesia.
    Waszczak BL; Lee EK; Ferraro T; Hare TA; Walters JR
    Brain Res; 1984 Jul; 306(1-2):307-18. PubMed ID: 6466980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
    Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR
    Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in substantia nigra pars reticulata activity following lesions of the substantia nigra pars compacta.
    Sanderson P; Mavoungou R; Albe-Fessard D
    Neurosci Lett; 1986 Jun; 67(1):25-30. PubMed ID: 3014391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of substantia nigra pars reticulata neurons to GABA and SKF 38393 in 6-hydroxydopamine-lesioned rats are differentially affected by continuous and intermittent levodopa administration.
    Weick BG; Engber TM; Susel Z; Chase TN; Walters JR
    Brain Res; 1990 Jul; 523(1):16-22. PubMed ID: 2119854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of nigral dopamine neurons by systemic and local apomorphine: possible contribution of dendritic autoreceptors.
    Akaoka H; Charléty P; Saunier CF; Buda M; Chouvet G
    Neuroscience; 1992 Aug; 49(4):879-91. PubMed ID: 1359456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-dopaminergic nigrostriatal pathway.
    Guyenet PG; Crane JK
    Brain Res; 1981 Jun; 213(2):291-305. PubMed ID: 7248760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the discharge rate of non-dopamine neurons in substantia nigra and ventral tegmental area and the motor activity induced by apomorphine.
    Olds ME
    Neuroscience; 1988 Feb; 24(2):465-76. PubMed ID: 3362349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substantia nigra as an out-put station for striatal dopaminergic responses: role of a GABA-mediated inhibition of pars reticulata neurons.
    Di Chiara G; Porceddu ML; Morelli M; Mulas ML; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):153-9. PubMed ID: 571967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supersensitivity of presynaptic receptors involved in the dopaminergic control of striatal high affinity glutamate uptake after 6-hydroxydopamine lesion of nigrostriatal dopaminergic neurons.
    Kerkerian L; Nieoullon A
    Exp Brain Res; 1988; 69(2):424-30. PubMed ID: 2894320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
    Olds ME
    Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
    Paladini CA; Celada P; Tepper JM
    Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (-)-Stepholidine acts as a D1 partial agonist on firing activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine-lesioned rats.
    Sun BC; Zhang XX; Jin GZ
    Life Sci; 1996; 59(4):299-306. PubMed ID: 8761001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata.
    Celada P; Paladini CA; Tepper JM
    Neuroscience; 1999 Mar; 89(3):813-25. PubMed ID: 10199615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of apomorphine-induced rotational behaviour by subthalamic lesion in 6-OHDA lesioned rats is associated with a normalization of firing rate and discharge pattern of pars reticulata neurons.
    Burbaud P; Gross C; Benazzouz A; Coussemacq M; Bioulac B
    Exp Brain Res; 1995; 105(1):48-58. PubMed ID: 7589317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal ganglia outflow pathways and circling behaviour in the rat.
    Leigh PN; Reavill C; Jenner P; Marsden CD
    J Neural Transm; 1983; 58(1-2):1-41. PubMed ID: 6418859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological properties of nigrothalamic neurons after 6-hydroxydopamine lesions in the rat.
    MacLeod NK; Ryman A; Arbuthnott GW
    Neuroscience; 1990; 38(2):447-56. PubMed ID: 2124665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.
    Przedborski S; Levivier M; Jiang H; Ferreira M; Jackson-Lewis V; Donaldson D; Togasaki DM
    Neuroscience; 1995 Aug; 67(3):631-47. PubMed ID: 7675192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.